BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6292011)

  • 1. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asymptomatic pancreatic islet cell tumor (glucagonoma): case report].
    Suto A; Takayama S; Miki H; Izumika H; Tanahashi T; Suzuki H; Takeshita T; Ohmiya H; Kijima H
    Nihon Geka Gakkai Zasshi; 1998 Feb; 99(2):124-8. PubMed ID: 9575509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
    Wilkinson DS
    Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The course of diabetes and clinical findings in glucagonoma].
    Teuscher A; Studer PP; Krebs A; Berger M; Aeberhard P
    Schweiz Med Wochenschr; 1979 Sep; 109(35):1273-80. PubMed ID: 524094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucagonoma syndrome. Report of a case.
    Domen RE; Shaffer MB; Finke J; Sterin WK; Hurst CB
    Arch Intern Med; 1980 Feb; 140(2):262-3. PubMed ID: 6243459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare combination consisting of primary hyperaldosteronism and glucagonoma.
    Abe H; Kubota K; Noie T; Kimura W; Makuuchi M
    Am J Gastroenterol; 1999 May; 94(5):1397-401. PubMed ID: 10235226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant endocrine tumor of the pancreas and ensuing clinical syndromes].
    Boumghar M
    J Chir (Paris); 1988 Mar; 125(3):174-7. PubMed ID: 2836444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
    Galle K; Schweiss D
    Hautarzt; 1984 Apr; 35(4):204-9. PubMed ID: 6327570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonoma syndrome and necrolytic migratory erythema.
    Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
    Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural studies of necrolytic migratory erythema.
    Ohyama K; Kitoh M; Arao T
    Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
    Manes G; Pellegrini A; Riccardi F; Uomo G
    Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The glucagon syndrome].
    Goldinger G; Aeberhard P
    Helv Chir Acta; 1980 Jun; 47(1-2):199-204. PubMed ID: 6254912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.